Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2013 1
2015 3
2017 2
2018 2
2019 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B, Kremer LC, van Dalen EC. Yalçin B, et al. Cochrane Database Syst Rev. 2015 Oct 5;2015(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. Cochrane Database Syst Rev. 2015. PMID: 26436598 Free PMC article. Review.
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is still poor; more than half of patients experience disease recurrence. ...SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing the e …
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is stil …
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B, Kremer LC, Caron HN, van Dalen EC. Yalçin B, et al. Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2015 Oct 05;(10):CD006301. doi: 10.1002/14651858.CD006301.pub4. PMID: 23970444 Updated. Review.
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is still poor; more than half of patients experience disease recurrence. ...OBJECTIVES: The primary objective was to compare the efficacy of myeloa …
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is stil …
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B, Kremer LC, Caron HN, van Dalen EC. Yalçin B, et al. Cochrane Database Syst Rev. 2010 May 12;(5):CD006301. doi: 10.1002/14651858.CD006301.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Aug 22;(8):CD006301. doi: 10.1002/14651858.CD006301.pub3. PMID: 20464740 Updated. Review.
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is still poor; more than half of patients experience disease recurrence. ...OBJECTIVES: To compare the effectiveness of myeloablative therapy with …
BACKGROUND: Despite the development of new treatment options, the prognosis of high-risk neuroblastoma patients is stil …
Rapid COJEC versus standard induction therapies for high-risk neuroblastoma.
Peinemann F, Tushabe DA, van Dalen EC, Berthold F. Peinemann F, et al. Cochrane Database Syst Rev. 2015 May 19;2015(5):CD010774. doi: 10.1002/14651858.CD010774.pub2. Cochrane Database Syst Rev. 2015. PMID: 25989478 Free PMC article. Review.
SELECTION CRITERIA: Randomized controlled trials evaluating the rapid COJEC induction schedule for high-risk neuroblastoma patients compared to standard induction schedules. ...Therefore, based on the currently available evidence, we are uncertain about the e …
SELECTION CRITERIA: Randomized controlled trials evaluating the rapid COJEC induction schedule for high-risk neuroblastoma …
Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.
Peinemann F, van Dalen EC, Enk H, Berthold F. Peinemann F, et al. Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010685. doi: 10.1002/14651858.CD010685.pub3. Cochrane Database Syst Rev. 2017. PMID: 28840597 Free PMC article. Review.
SELECTION CRITERIA: Randomised controlled trials (RCTs) evaluating additional retinoic acid after HDCT followed by HSCT for people with high-risk neuroblastoma compared to placebo retinoic acid or to no additional retinoic acid. ...Based on the currently avai …
SELECTION CRITERIA: Randomised controlled trials (RCTs) evaluating additional retinoic acid after HDCT followed by HSCT for people with h …
A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma.
Herd F, Basta NO, McNally RJQ, Tweddle DA. Herd F, et al. Eur J Cancer. 2019 Apr;111:50-58. doi: 10.1016/j.ejca.2018.12.032. Epub 2019 Feb 26. Eur J Cancer. 2019. PMID: 30822684 Free PMC article.
BACKGROUND: Despite aggressive multimodal therapy, >50% of children with high-risk neuroblastoma (HRNB) relapse. Survival after relapse is rare, and no consensus currently exists on the most effective therapy. ...
BACKGROUND: Despite aggressive multimodal therapy, >50% of children with high-risk neuroblastoma (HRNB) relapse. Sur …
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation.
Peinemann F, van Dalen EC, Tushabe DA, Berthold F. Peinemann F, et al. Cochrane Database Syst Rev. 2015 Jan 29;1:CD010685. doi: 10.1002/14651858.CD010685.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2017 Aug 25;8:CD010685. doi: 10.1002/14651858.CD010685.pub3. PMID: 25634649 Updated. Review.
Retinoic acid has been shown to inhibit growth of human neuroblastoma cells and has been considered as a potential candidate for improving the outcome of patients with high-risk neuroblastoma. OBJECTIVES: To evaluate efficacy and adverse events of retinoic ac …
Retinoic acid has been shown to inhibit growth of human neuroblastoma cells and has been considered as a potential candidate for improving t …
The Evidence for External Beam Radiotherapy in High-Risk Neuroblastoma of Childhood: A Systematic Review.
Arumugam S, Manning-Cork NJ, Gains JE, Boterberg T, Gaze MN. Arumugam S, et al. Clin Oncol (R Coll Radiol). 2019 Mar;31(3):182-190. doi: 10.1016/j.clon.2018.11.031. Epub 2018 Dec 1. Clin Oncol (R Coll Radiol). 2019. PMID: 30509728
The purpose of this systematic review was to survey the published literature to identify, without bias, the evidence for the clinical effectiveness of external beam radiotherapy as part of the initial multimodality treatment of high-risk neuroblastoma. We con …
The purpose of this systematic review was to survey the published literature to identify, without bias, the evidence for the clinical effect …
Impact of extent of resection on survival in high-risk neuroblastoma: A systematic review and meta-analysis.
Yang X, Chen J, Wang N, Liu Z, Li F, Zhou J, Tao B. Yang X, et al. J Pediatr Surg. 2019 Jul;54(7):1487-1494. doi: 10.1016/j.jpedsurg.2018.08.046. Epub 2018 Sep 6. J Pediatr Surg. 2019. PMID: 30262202
Studies of pediatric patients with newly diagnosed high-risk neuroblastoma comparing various EOR and presenting objective overall or event-free survival data were included. ...CONCLUSION: This literature highlights the importance of "extent of resection" in t …
Studies of pediatric patients with newly diagnosed high-risk neuroblastoma comparing various EOR and presenting objecti …
13 results